Search Within

Morton Schwartz

Formats
  1. Meeting Abstract (94)
  2. Journal Article (84)
  3. Conference Paper (7)
  4. Book Section (1)
Groups
  1. Department of Medicine (19)
  2. Solid Tumor Oncology Division (15)
  3. Genitourinary Oncology Service (12)
  4. Nursing (6)
  5. Survivorship Research (6)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)

More Groups

People
  1. Ann Dnistrian (47)
  2. Delia Schwartz (45)
  3. Carol Smith (39)
  4. Martin Fleisher (26)
  5. Ernest Greenberg (14)
  6. Ravi Bhalla (14)

More People

Years
  1. 2005 (1)
  2. 2003 (2)
  3. 2002 (11)
  4. 2001 (6)
  5. 2000 (10)
  6. 1999 (13)

More Years

Publications
  1. Clinical Chemistry (86)
  2. Tumor Biology (7)
  3. Breast Cancer Research and Treatment (6)
  4. Journal of Clinical Oncology (6)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (6)
  6. Clinica Chimica Acta (5)

More Publications

Publishers
  1. American Association for Clinical Chemistry (86)
  2. Oxford University Press (8)
  3. Springer (8)
  4. Springer Netherlands (7)
  5. American Association for Cancer Research (6)
  6. American Society of Clinical Oncology (6)

More Publishers

Results (186)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Variation in the quantitation of prostate-specific antigen in reference material: Differences in commercial immunoassays
    Journal Article

    Cheli, C. D.; Marcus, M.; Levine, J.; Zhou, Z.; Anderson, P. H.; Bankson, D. D.; Bock, J.; Bodin, S.; Eisen, C.; Senior, M.; more...
    Clinical Chemistry (1998)

    Fulltext@MSK | Save
  • Evaluation of the CA15-3™ assay (breast cancer marker) on the Technicon Immuno 1® system
    Meeting Abstract

    Smith, C.; Schwartz, M. K.; Dnistrian, A.; Hudis, C.; Schwartz, D. L.; Morris, D.
    Clinical Chemistry (1997)

    Fulltext@MSK | Save
  • Alpha FetoProtein (AFP) and chorionic gonadotropin (hCG) assayed simultaneously by the Technicon Immuno 1® System in the serum of men with testicular cancer
    Meeting Abstract

    Schwartz, M. K.; Smith, C.; Dnistrian, A.; Fleisher, M.; Schwartz, D.; Neaman, I.
    Clinical Chemistry (1997)

    Fulltext@MSK | Save
  • Setting the stage: An introduction to the current status of tumor marker testing
    Journal Article

    Schwartz, M. K.
    Tumor Markers: Reclassification, Reimbursement & Recent Advances (1997)

    Fulltext@MSK | Save
  • A pragmatic review of tumor markers risk assessment analysis (screening)
    Conference Paper

    Schwartz, M. K.
    Clinical Ligand Assay Society (1997)

    Fulltext@MSK | Save
  • Bicalutamide for advanced prostate cancer: The natural versus treated history of disease
    Journal Article

    Scher, H. I.; Liebertz, C.; Kelly, W. K.; Mazumdar, M.; Brett, C.; Schwartz, L.; Kolvenbag, G.; Shapiro, L.; Schwartz, M.
    Journal of Clinical Oncology (1997)

    Fulltext@MSK | Save
  • Emerging tumor markers
    Meeting Abstract

    Schwartz, M. K.
    Tumor Biology (1996)

    Fulltext@MSK | Save
  • Clinical evaluation comparing AxSYM CA 15-3 and IMx CA 16-3
    Meeting Abstract

    Lynch, D.; Gross, M.; Knuckles, H.; O'Morchoe, S.; Weatherholt, J.; Weigand, R.; Chan, D.; Haven, M.; Painter, P.; Schwartz, M.; more...
    Clinical Chemistry (1996)

    Fulltext@MSK | Save
  • Management program for bedside blood glucose monitoring
    Meeting Abstract

    Menendez-Botet, C. J.; Celucia, F.; Dorsa, R.; Schwartz, M. K.
    Clinical Chemistry (1996)

    Fulltext@MSK | Save
  • Technicon Immuno 1® prostate specific antigen (PSA) Assay is precise, ultrasensitive and insensitive to complexation of PSA
    Meeting Abstract

    Morris, D. L.; Dillon, P.; Chan, D. W.; Fritsche, H. A.; Schwartz, M. K.; Vessella, R. L.; Yeung, K. K.; Allard, W. J.
    Clinical Chemistry (1996)

    Fulltext@MSK | Save